CCDC92 Inhibitors
Chemical inhibitors of CCDC92 function by disrupting various stages of vesicular trafficking and membrane dynamics within the cell. Wortmannin and LY294002, both phosphoinositide 3-kinase inhibitors, directly affect the signaling pathways necessary for the initiation and maturation of vesicles. By inhibiting PI3K, these chemicals prevent the phosphorylation of downstream targets, which is essential for vesicular formation, movement, and the sorting of cargo. This results in a functional inhibition of CCDC92, which is thought to play a role in these vesicle-mediated processes. Similarly, the microtubule-stabilizing agent Paclitaxel, by preventing microtubule disassembly, can affect vesicle transport along the cytoskeleton, thereby influencing the function of CCDC92 in vesicle trafficking.
Dynasore and MiTMAB are inhibitors that target the GTPase activity of dynamin, a protein crucial for the scission of clathrin-coated vesicles from the plasma membrane. The inhibition of dynamin leads to the accumulation of unscissored vesicles, consequently impeding the normal trafficking process that CCDC92 is believed to be involved in. Chlorpromazine and Pitstop 2 hinder clathrin-mediated endocytosis by different mechanisms. Chlorpromazine disrupts the assembly of clathrin and adaptor proteins, while Pitstop 2 blocks the interaction between clathrin and its adaptor proteins. Both actions result in a failure to form clathrin-coated vesicles, which are pivotal in endocytosis, a process with which CCDC92 is associated. Bafilomycin A1, by inhibiting the V-ATPase, disrupts the acidification of organelles and vesicles, a critical step in protein sorting and trafficking, thus affecting CCDC92's role in these processes. Monensin, as an ionophore, disrupts ion gradients, undermining lysosomal acidification and protein trafficking, which can impede CCDC92's function. Lastly, Genistein, by inhibiting tyrosine kinase activity, can prevent the phosphorylation of proteins involved in the regulation of vesicular trafficking, potentially affecting CCDC92's activity in these cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent phosphoinositide 3-kinase inhibitor which disrupts PI3K-related pathways. CCDC92, involved in membrane dynamics and trafficking, may rely on PI3K activity for its function. Inhibition of PI3K by Wortmannin can lead to a reduction in membrane trafficking efficacy, thereby functionally inhibiting CCDC92. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of phosphoinositide 3-kinases. By inhibiting PI3K, LY294002 can decrease the phosphorylation of downstream targets essential for vesicular formation and trafficking. As CCDC92 is associated with cellular trafficking, its function can be inhibited by LY294002 due to the reduced formation and movement of vesicles within the cell. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small molecule that inhibits dynamin, a GTPase involved in the scission of clathrin-coated vesicles from the membrane. As CCDC92 is thought to play a role in vesicular trafficking, the inhibition of dynamin by Dynasore can lead to an accumulation of unscissored vesicles, inhibiting the trafficking process and the function of CCDC92. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is an inhibitor of clathrin-mediated endocytosis. By inhibiting the assembly of clathrin and associated adaptor proteins, Chlorpromazine can disrupt vesicle formation, which is essential for intracellular trafficking. This disruption can functionally inhibit CCDC92 by preventing the formation of vesicles that CCDC92 might interact with or regulate. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the vacuolar-type H+-ATPase (V-ATPase). By inhibiting V-ATPase, Bafilomycin A1 impairs the acidification of organelles and vesicles, which is crucial for protein sorting and trafficking. CCDC92, which is involved in vesicle-mediated processes, can be functionally inhibited due to the dysregulation of vesicle acidification. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is an inhibitor of clathrin terminal domain, preventing the interaction between clathrin and its adaptor proteins, thus inhibiting clathrin-mediated endocytosis. As CCDC92 is involved in vesicle trafficking, the inhibition of clathrin function by Pitstop 2 can result in the functional inhibition of CCDC92 by blocking vesicle formation and transport. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can also inhibit the phosphorylation of multiple proteins involved in various signaling pathways. Given that CCDC92 may require phosphorylation for its function in vesicle trafficking or membrane dynamics, the inhibition of tyrosine kinases by Genistein can lead to an inhibition of CCDC92's functional role in these processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular ion gradients, particularly sodium and hydrogen ions. It disrupts lysosomal acidification and protein trafficking. By altering the ion balance, Monensin can affect vesicle trafficking and organelle function. This can functionally inhibit CCDC92 by impeding the vesicular transport and organelle maintenance that CCDC92 may regulate. | ||||||